We report normative data for a Turkish translation of the Current Symptoms Scale (CSS), a screening measure of adult attention-deficit/hyperactivity disorder (ADHD). The CSS yields 3 scores reflecting diagnostic criteria for: (1) ADHD, predominantly hyperactive-impulsive type; (2) ADHD, predominantly inattentive type, and (3) ADHD, combined type. For comparison purposes, we also present normative data from a community sample in the United States. Central tendency, variability, and correlation patterns among Turkish subjects (n = 181) were similar to patterns demonstrated by respondents in the United States (n = 114). Mann-Whitney U tests revealed that the Turkish and US groups did not differ significantly on the subscales assessing inattentive and hyperactive-impulsive symptoms. Both versions demonstrated acceptable levels of internal consistency (Cronbach’s alpha coefficients ranged from 0.65 to 0.78 for the Turkish version, and from 0.63 to 0.75 for the English version). The Turkish version of the CSS demonstrated excellent test- retest reliability. The test-retest coefficient for the CSS (total score) was 0.82. The inattentive type subscale also showed good test-retest reliability, with r = 0.78. The test-retest coefficient for the hyperactive-impulsive type subscale was appreciably lower, with r = 0.68; albeit, in the acceptable range. Investigators have determined that many adults, initially diagnosed with ADHD as children, continue to demonstrate clinically significant symptoms. Since adult ADHD is associated with a number of comorbid psychiatric conditions and treatment of the underlying attentional, executive, and impulse control difficulties is associated with a reduction in comorbid psychiatric symptoms, the routine screening for adult ADHD in psychiatric and mental health settings may be warranted.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.